PhoenixBio Co Ltd (6190):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PhoenixBio Co Ltd (6190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8022
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blood biochemical measurements. It uses PXB-Mouse, a chimeric mouse with a humanized liver for use in drug discovery and early development. PhoenixBio’s study services include DMPK studies; safety studies; viral hepatitis-related studies; efficacy and safety studies for human specific nucleic acids, antibody, or polypeptide medicines; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The company operates in Japan and the US. PhoenixBio is headquartered in Higashihiroshima, Japan.

PhoenixBio Co Ltd (6190) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
PhoenixBio to Raise USD1.3 Million in Private Placement of Shares 10
PhoenixBio Raises USD6.4 Million in IPO 11
Acquisition 12
PhoenixBio to Acquire KMT Hepatech for USD4.3 Million 12
PhoenixBio Co Ltd – Key Competitors 13
PhoenixBio Co Ltd – Key Employees 14
PhoenixBio Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Jun 29, 2018: Promotion of New President & CEO of PhoenixBio and PhoenixBio USA – Hiroshima, Japan, June 29th, 2018 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoenixBio Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PhoenixBio to Raise USD1.3 Million in Private Placement of Shares 10
PhoenixBio Raises USD6.4 Million in IPO 11
PhoenixBio to Acquire KMT Hepatech for USD4.3 Million 12
PhoenixBio Co Ltd, Key Competitors 13
PhoenixBio Co Ltd, Key Employees 14
PhoenixBio Co Ltd, Subsidiaries 15

List of Figures
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PhoenixBio Co Ltd (6190):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ENN Energy Holdings Ltd (2688):企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • In’Tech Medical SAS-医療機器分野:企業M&A・提携分析
    Summary In'Tech Medical SAS (In'Tech Medical) is a medical device company that offers surgical equipment. The company designs, develops and manufactures orthopedic implants and instruments for the healthcare sector. Its surgical instruments include benders, calipers, cervical pin distractor, angled …
  • Cohu, Inc. (COHU):企業の財務・戦略的SWOT分析
    Cohu, Inc. (COHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Solent NHS Trust:企業の戦略的SWOT分析
    Solent NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Electricity Generating Public Co Ltd:発電所・企業SWOT分析
    Electricity Generating Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Martifer SGPS SA (MAR)-エネルギー分野:企業M&A・提携分析
    Summary Martifer SGPS S.A. (Martifer) is an industrial holding company. Through its subsidiaries, the company provides construction services to metal mechanical structures, aluminum and glass facades, and infrastructure facilities. It promotes and develops renewable energy projects in the wind secto …
  • Big Lots, Inc.:企業の戦略・SWOT・財務情報
    Big Lots, Inc. - Strategy, SWOT and Corporate Finance Report Summary Big Lots, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • University of Leeds:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological science …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • StageZero Life Sciences Ltd (GEN):企業の財務・戦略的SWOT分析
    Summary StageZero Life Sciences Ltd (StageZero Life Sciences) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of b …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • Pioneer Energy Services Corp (PESX):企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PESX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Toto Ltd:企業の戦略・SWOT・財務情報
    Toto Ltd - Strategy, SWOT and Corporate Finance Report Summary Toto Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • The Emirates Group:企業の戦略・SWOT・財務情報
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Toro Company:企業の戦略・SWOT・財務情報
    The Toro Company - Strategy, SWOT and Corporate Finance Report Summary The Toro Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cranswick plc:企業の戦略・SWOT・財務情報
    Cranswick plc - Strategy, SWOT and Corporate Finance Report Summary Cranswick plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • FMC Corporation:企業の戦略・SWOT・財務情報
    FMC Corporation - Strategy, SWOT and Corporate Finance Report Summary FMC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆